Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

urothelial carcinoma

  • You have access
    Value of Uroplakin III in Distinguishing Variants of Primary Bladder Urothelial Carcinoma from Malignancy Metastatic to the Urinary Bladder
    KIARA KLOPFER, BRETT DELAHUNT, MICHAEL ADAMSON and HEMAMALI SAMARATUNGA
    Anticancer Research November 2014, 34 (11) 6779-6784;
  • You have access
    The Angiopoietin-Tie2 Pathway Is a Potential Therapeutic Target in Urothelial Carcinoma
    WEIGUO JIAN, JONATHAN M. LEVITT, SETH P. LERNER and GURU SONPAVDE
    Anticancer Research July 2014, 34 (7) 3377-3382;
  • You have access
    The Preclinical Activity of Lenalidomide in Indolent Urothelial Carcinoma
    WEIGUO JIAN, JONATHAN M. LEVITT, SETH P. LERNER and GURU SONPAVDE
    Anticancer Research July 2014, 34 (7) 3383-3389;
  • You have access
    FIP-gts Potentiate Autophagic Cell Death Against Cisplatin-resistant Urothelial Cancer Cells
    JIAN-RI LI, CHEN-LI CHENG, WAN-JUNG YANG, CHI-REI YANG, YEN-CHUAN OU, MING-JU WU and JIUNN-LIANG KO
    Anticancer Research June 2014, 34 (6) 2973-2983;
  • You have access
    Adjuvant Radiotherapy for Stage III/IV Urothelial Carcinoma of the Upper Tract
    EUNJIN JWA, YOUNG SEOK KIM, HANJONG AHN, CHOUNG-SOO KIM, JAE-LYUN LEE, SEON OK KIM and SEUNG DO AHN
    Anticancer Research January 2014, 34 (1) 333-338;
  • You have access
    Factors Predictive of Oncological Outcome After Nephroureterectomy: Comparison Between Laparoscopic and Open Procedures
    KOUJI IZUMI, SHINGO ITAI, YOSHIKO TAKAHASHI, RIE TAKAHASHI, AERKEN MAOLAKE, MITSUO OFUDE, SATORU UENO, YOSHIFUMI KADONO, YASUHIDE KITAGAWA, HIROYUKI KONAKA, ATSUSHI MIZOKAMI and MIKIO NAMIKI
    Anticancer Research December 2013, 33 (12) 5501-5506;
  • You have access
    Utility of ATP7B in Prediction of Response to Platinum-based Chemotherapy in Urothelial Bladder Cancer
    SEBASTIAN CHRISTOPH SCHMID, TIBOR SCHUSTER, THOMAS HORN, JÜRGEN GSCHWEND, UWE TREIBER and GREGOR WEIRICH
    Anticancer Research September 2013, 33 (9) 3731-3737;
  • You have access
    Alpha-fetoprotein-producing Carcinoma of the Renal Pelvis Exhibiting Hepatoid and Urothelial Differentiation
    HEMAMALI SAMARATUNGA, DINITHI SAMARATUNGA, NIGEL DUNGLISON, JOANNA PERRY-KEENE, JAMES NICKLIN and BRETT DELAHUNT
    Anticancer Research November 2012, 32 (11) 4987-4991;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire